Company intelligence / Profile preview
WhanIn Pharm
- Ownership
- Private
- Employees
- ~520
- Development stage
- Other
Overview
WhanIn Pharm is a prominent South Korean pharmaceutical company primarily focused on treatments for the Central Nervous System (CNS). Founded in 1978, the company has established itself as a market leader in the Korean psychiatry and neurology sectors, offering a robust portfolio of drugs for depression, schizophrenia, and epilepsy. Beyond its core CNS strength, WhanIn Pharm also develops and markets therapies for circulatory disorders, gastrointestinal issues, and metabolic diseases. The company is actively expanding its R&D pipeline with both novel chemical entities and high-value generic formulations to maintain its competitive edge in the domestic and international healthcare markets.
- Therapeutic areas
- PsychiatryNeurologyGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
12 assets11 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on WhanIn Pharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on WhanIn Pharm.